A structured monitoring plan typically includes: Baseline labs : HbA1c, fasting glucose, kidney function, and lipid profile before starting Gradual dose escalation : starting at the lowest dose for 4 weeks and increasing only if tolerated, to minimise nausea Follow-up HbA1c : usually at 12 weeks to confirm the medication is working as expected Weight and waist circumference tracking : alongside diet and activity counselling, since medication alone rarely sustains results without lifestyle support Screening for rare but serious side effects , including pancreatitis symptoms and gallbladder issues, especially in the first few months what happens if you stop treatment : check full details Patients on continuous glucose monitoring often see the clearest, fastest feedback on how their body responds to either option one more reason a supervised program beats a self-directed one
Mental health checks are often brief questionnaires
(If the test cannot be completed temporarily, the supernatant can be stored at -80 for 10 days.) Blood sample Plasma: Sample is centrifuged at 600 g for 10 minutes at 4
When to Adjust the GLP-1 Dose Itself Dose modification of the GLP-1 agonist should be reserved for cases where electrolyte correction, hydration optimization, and co-medication adjustments have failed to resolve cramps after 4-6 weeks